The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma.
We investigated the influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma. Between February 1999 and December 2006, 153 patients with hepatocellular carcinoma underwent living donor liver transplantation at our center. Recurrence-free and overall survival was compared between patients with blood transfusion and those without transfusion in red blood cells, fresh frozen plasma, or platelet concentrate. Recurrence-free survival was significantly higher in the platelet concentrate transfused group than in the group without platelet concentrate transfusion (P=0.003), although there were no significant differences between the three transfused groups and the non-transfused groups in overall survival. The platelet concentrate transfused group had more patients within the preoperative Milan criteria (P=0.014) and more patients with Child-Pugh C classification (P<0.001). Recurrence-free survival after liver transplantation for hepatocellular carcinoma was significantly higher in the platelet concentrate transfused group than the group without platelet concentrate transfusion.